Sodium selenite-induced apoptosis in murine B-lymphoma cells is associated with inhibition of protein kinase C-δ, nuclear factor κB, and inhibitor of apoptosis protein

Toxicological Sciences

Volumn 78, Issue 2, 2004, Pages 204-214

  Gopee, Neera V ^a,b   Johnson, Victor J ^a,c   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Cellular inhibitor of apoptosis protein 2; Nuclear factor B; Phorbol 12 myristate 13 acetate; Protein kinase C ; Selenium

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C DELTA; SODIUM SELENITE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL CYCLE G2 PHASE; CELL DEATH; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DNA BINDING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; FLOW CYTOMETRY; IN VITRO STUDY; INCUBATION TIME; LYMPHOMA CELL; LYMPHOMA CELL LINE; MEMBRANE TRANSPORT; NONHUMAN; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; NF-KAPPA B; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEINS; SODIUM SELENITE; TETRADECANOYLPHORBOL ACETATE;

MURINAE;

EID: 2342438956     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh072     Document Type: Article

References (79)

1. Allan, C. B., Lacourciere, G. M., and Stadtman, T. C. (1999). Responsiveness of selenoproteins to dietary selenium. Annu. Rev. Nutr. 19, 1-16.
2. Baeuerle, P. A. (1991). The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim. Biophys. Acta 1072, 63-80.
3. Bellas, R. E., Fitzgerald, M. J., Fausto, N., and Sonenshein, G. E. (1997). Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151, 891-896.
4. 2/M DNA damage checkpoint during oxidative stress. Environ. Mol. Mutagen. 33, 144-152.
5. Blank, R. S., Thompson, M. M., and Owens, G. K. (1988). Cell cycle versus density dependence of smooth muscle α actin expression in cultured rat aortic smooth muscle cells. J. Cell Biol. 107, 299-306.
6. Blumberg, P. M. (1988). Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth Rhoads memorial award lecture. Cancer Res. 48, 1-8.
7. Buchner, K. (2000). The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J. Cancer Res. Clin. Oncol. 126, 1-11.
8. Chmura, S. J., Nodzenski, E., Weichselbaum, R. R., and Quintans, J. (1996). Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56, 2711-2714.
9. Cho, D. Y., Jung, U., and Chung, A. S. (1999). Induction of apoptosis by selenite and selenodiglutathione in HL-60 cells: Correlation with cytotoxicity. Biochem. Mol. Biol. Int. 47, 781-793.
10. 1 renal epithelia. Kidney Int. 58, 1004-1015.
11. Combs, G. F., Jr., and Gray, W. P. (1998). Chemopreventive agents: selenium. Pharmacol. Ther. 79, 179-192.
12. Cross, T., Griffiths, G., Deacon, E., Sallis, R., Gough, M., Watters, D., and Lord, J. M. (2000). PKC-δ is an apoptotic lamin kinase. Oncogene 19, 2331-2337.
13. Cryns, V., and Yuan, J. (1998). Proteases to die for. Genes Dev. 12, 1551-1570.
14. El-Bayoumy, K., DeVita, V., Hellman, S., and Rosenberg, S. A. (1991). The role of selenium in cancer prevention. In Cancer Principles and Practice of Oncology, 4th ed.(DeVita, V. T., Hellman, S., and Rosenberg, S. A., Ed.), pp. 1-15. Lippincott, Philadelphia..
15. 1 cyclin expression. J. Biol. Chem. 272, 13816-13822.
16. Ganther, H. E. (1986). Pathways of selenium metabolism including respiratory excretory products. J. Am. Coll. Toxicol. 5, 1-5.
17. Gopalakrishna, R., Chen, Z. H., and Gundimeda, U. (1995). Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors. Methods Enzymol. 252, 132-146.
18. Gopalakrishna, R., Chen, Z. H., and Gundimeda, U. (1997). Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: Its role in inhibition of tumor promotion. Arch. Biochem. Biophys. 348, 37-48.
19. Gopalakrishna, R., and Gundimeda, U. (2001). Protein kinase C as a molecular target for cancer prevention by selenocompounds. Nutr. Cancer 40, 55-63.
20. Gopalakrishna, R., and Gundimeda, U. (2002). Antioxidant regulation of protein kinase C in cancer prevention. J. Nutr. 132, 3819S-3823S.
21. 1 cytotoxicity. Toxicology, 187, 239-250.
22. 1 cells. Chem-Biol Interact. 146, 31-46.
23. Grilli, M., Chiu, J. J., and Lenardo, M. J. (1993). NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62.
24. Ip, C., Thompson, H. J., and Ganther, H. E. (2000). Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol. Biomarkers Prev. 9, 49-54.
25. Jiang, C., Wang, Z., Ganther, H., and Lu, J. (2001). Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res. 61, 3062-3070.
26. Kiley, S. C., Clark, K. J., Duddy, S. K., Welch, D. R., and Jaken, S. (1999). Increased protein kinase C-δ in mammary tumor cells: relationship to transformtion and metastatic progression. Oncogene 18, 6748-6757.
27. Kim, I. Y., and Stadtman, T. C. (1997). Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc. Natl. Acad. Sci. U.S.A. 94, 12904-12907.
28. Kim, S.-H., Johnson, V. J., and Sharma, R. P. (2004). Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-κB signaling pathways. Exp. Biol. Med 229, 203-213.
29. Kim, T., Jung, U., Cho, D. Y., and Chung, A. S. (2001). Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells. Carcinogenesis 22, 559-565.
30. Kontny, E., Kurowska, M., Szczepanska, K., and Maslinski, W. (2000). Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes. J. Leukoc. Biol. 67, 249-258.
31. Kretz-Remy, C. and Arrigo, A. P. (2001). Selenium: A key element that controls NF-κB activation and IκB α half life. Biofactors 14, 117-125.
32. Lanfear, J., Fleming, J., Wu, L., Webster, G., and Harrison, P. R. (1994). The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium? Carcinogenesis 15, 1387-1392.
33. Leach, S. D., Scatena, C. D., Keefer, C. J., Goodman, H. A., Song, S. Y., Yang, L., and Pietenpol, J. A. (1998). Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res. 58, 3231-3236.
34. Li, J., Zuo, L., Shen, T., Xu, C. M., and Zhang, Z. N. (2003). Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: Involvement of oxidative stress and mitochondria. J. Trace Elem. Med. Biol 17, 19-26.
35. Lu, J., Jiang, C., Kaeck, M., Ganther, H., Vadhanavikit, S., Ip, C., and Thompson, H. (1995). Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem. Pharmacol. 50, 213-219.
36. Lu, J., Kaeck, M., Jiang, C., Wilson, A. C., and Thompson, H. J. (1994). Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol. 47, 1531-1535.
37. Medina, D., and Oborn, C. J. (1984). Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN-4. Cancer Res. 44, 4361-4365.
38. Mellor, H., and Parker, P. J. (1998). The extended protein kinase C superfamily. Biochem. J. 332, 281-292.
39. Menter, D. G., Sabichi, A. L., and Lippman, S. M. (2000). Selenium effects on prostate cell growth. Cancer Epidemiol. Biomarkers Prev. 9, 1171-1182.
40. Milner, J. A., and Hsu, C. Y. (1981). Inhibitory effects of selenium on the growth of L1210 leukemic cells. Cancer Res. 41, 1652-1656.
41. Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., and Anderson, K. C. (2002). Biologic sequelae of nuclear factor-κB blockade in multiple myeloma: Therapeutic applications. Blood 99, 4079-4086.
42. Nano, J. L., Czerucka, D., Menguy, F., and Rampal, P. (1989). Effect of selenium on the growth of three human colon cancer cell lines. Biol. Trace Elem. Res. 20, 31-43.
43. Pahl, H. L. (1999). Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866.
44. Park, H. S., Huh, S. H., Kim, Y., Shim, J., Lee, S. H., Park, I. S., Jung, Y. K., Kim, I. Y., and Choi, E. J. (2000). Selenite negatively regulates caspase-3 through a redox mechanism. J. Biol. Chem. 275, 8487-8491.
45. Pines, J. (1994). The cell cycle kinases. Semin. Cancer Biol. 5, 305-313.
46. Pines, J. (1995). Cyclins, CDKs and cancer. Semin. Cancer Biol. 6, 63-72.
47. Pongracz, J., Webb, P., Wang, K., Deacon, E., Lunn, O. J., and Lord, J. M. (1999). Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-δ. J. Biol. Chem. 274, 37329-37334.
48. Quest, A. F., Bloomenthal, J., Bardes, E. S., and Bell, R. M. (1992). The regulatory domain of protein kinase C coordinates four atoms of zinc. J. Biol. Chem. 267, 10193-10197.
49. Reyland, M. E., Anderson, S. M., Matassa, A. A., Barzen, K. A., and Quissell, D. O. (1999). Protein kinase C-δ is essential for etoposide-induced apoptosis in salivary gland acinar cells. J. Biol. Chem. 274, 19115-19123.
50. Schulze-Osthoff, K., Los, M., and Baeuerle, P. A. (1995). Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50, 735-741.
51. Sellins, K. S., and Cohen, J. J. (1987). Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139, 3199-3206.
52. Sen, R., and Baltimore, D. (1986). Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47, 921-928.
53. Sharma, K., Mittal, D. K., Kesarwani, R. C., Kamboj, V. P., and Chowdhery, A. R. (1994). Diagnostic and prognostic significance of serum and tissue trace elements in breast malignancy. Indian J. Med. Sci. 48, 227-232.
54. Shen, H. M., Yang, C. F., and Ong, C. N. (1999). Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int. J. Cancer 81, 820-828.
55. Shih, N. Y., and Floyd-Smith, G. (1995). Invariant chain (CD74) gene regulation: Enhanced expression associated with activation of protein kinase C delta in a murine B lymphoma cell line. Mol. Immunol. 32, 643-650.
56. Shizukuda, Y., Reyland, M. E., and Buttrick, P. M. (2002). Protein kinase C-δ modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am. J. Physiol Heart Circ. Physiol 282, H1625-H1634.
57. Sinha, R., Kiley, S. C., Lu, J. X., Thompson, H. J., Moraes, R., Jaken, S., and Medina, D. (1999). Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett. 146, 135-145.
58. Sinha, R., Said, T. K., and Medina, D. (1996). Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett. 107, 277-284.
59. Spallholz, J. E., Martin, J. L., Gerlach, M. L., and Heinzerling, R. H. (1973). Enhanced immunoglobulin M and immunoglobulin G antibody titers in mice fed selenium. Infect. Immun. 8, 841-842.
60. Spyrou, G., Bjornstedt, M., Kumar, S., and Holmgren, A. (1995). AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett. 368, 59-63.
61. Spyrou, G., Bjornstedt, M., Skog, S., and Holmgren, A. (1996). Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res. 56, 4407-4412.
62. Stadtman, T. C. (1996). Selenocysteine. Annu. Rev. Biochem. 65, 83-100.
63. Stewart, M. S., Davis, R. L., Walsh, L. P., and Pence, B. C. (1997). Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett. 117, 35-40.
64. Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A., Andreeff, M., and Reed, J. C. (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 6, 1796-1803.
65. Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
66. Thompson, H. J., Wilson, A., Lu, J., Singh, M., Jiang, C., Upadhyaya, P., el Bayoumy, K., and Ip, C. (1994). Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15, 183-186.
67. Turner, R. J., Wheatley, L. E., and Beck, N. F. (1985). Stimulatory effects of selenium on mitogen responses in lambs. Vet. Immunol. Immunopathol. 8, 119-124.
68. Vertegaal, A. C., Kuiperij, H. B., Yamaoka, S., Courtois, G., van der Eb, A. J., and Zantema, A. (2000). Protein kinase C-α is an upstream activator of the IκB kinase complex in the TPA signal transduction pathway to NF-κB in U2OS cells. Cell Signal. 12, 759-768.
69. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998). NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
70. Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U., and Nishizuka, Y. (1992). Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc. Natl. Acad. Sci. U.S.A. 89, 10159-10163.
71. Watson, R. R., Moriguchi, S., McRae, B., Tobin, L., Mayberry, J. C., and Lucas, D. (1986). Effects of selenium in vitro on human T-lymphocyte functions and K-562 tumor cell growth. J. Leukoc. Biol. 39, 447-456.
72. 2 receptor coupled to NF-κB. Am. J. Physiol. Renal Physiol. 278, F270-F278.
73. Weisberger, A. S., and Suhrland, L. G. (1956). Studies on analogues of L-cysteine and L-cystine. II. The effect of selenium cystine on Murphy lymphosarcoma tumor cells in the rat. Blood 11, 11-18.
74. Wilson, A. C., Thompson, H. J., Schedin, P. J., Gibson, N. W., and Ganther, H. E. (1992). Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem. Pharmacol. 43, 1137-1141.
75. Woo, M., Lee, H., Belles, R. E., Schemer, S. L., Assure, M., Katz, D., Fitzgerald, M. J., Rothstein, T. L., Sherr, D. H., and Sonenshein, G. E. (1996). Inhibition of NF-kappa B/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682-4690.
76. Yoon, S. O., Kim, M. M., and Chung, A. S. (2001). Inhibitory effect of selenite on invasion of HT1080 tumor cells. J. Biol. Chem. 276, 20085-20092.
77. Zeng, H. (2002). Selenite and selenomethionine promote HL-60 cell cycle progression. J. Nutr. 132, 674-679.
78. Zhong, M., Lu, Z., and Foster, D. A. (2002). Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene 21, 1071-1078.
79. Zhu, S., Gray, T. E., and Nettesheim, P. (1992). The effect of sodium selenite on cell proliferation and transformation of primary rat tracheal epithelial cells. Carcinogenesis 13, 1725-1729.